Lamictal Drug Buyers Lose Another Class Certification Bid
By Ryan Harroff · February 2, 2023, 3:25 PM EST
A proposed class of drug wholesalers accusing GlaxoSmithKline PLC and Teva Pharmaceuticals Ltd. of suppressing the generic competition to the epilepsy treatment and mood stabilizer Lamictal has failed to convince a...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login